Related Experiment Video
Updated: Oct 23, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
miR-128 participates in the pathogenesis of chronic constipation by regulating the p38α/M-CSF inflammatory signaling
Yuntian Hong1,2,3, Xianghai Ren1,2,3,4,5, Weicheng Liu1,2,3,4,5
1Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Abstract:
Chronic constipation (CC) is a gastrointestinal disorder that adversely affects the quality of life. MicroRNAs are involved in the pathogenesis of functional gastrointestinal disorders. This study aims to investigate the molecular mechanism of microRNA-128 in CC. Here, we successfully constructed a murine model of CC based on morphine and rhubarb. The expression of stem cell factor (SCF) and neuron-specific enolase (NSE) was low in the models. Using miRNA array and bioinformatic analysis, we predicted and confirmed the expression of miR-128 and its downstream target genes in CC model. Compared with the control group, CC group showed a significant downregulation of miR-128 and upregulation of p38α and macrophage colony-stimulating factors (M-CSFs). Moreover, we observed elevated inflammatory cytokine and decreased anti-inflammatory cytokine levels in colonic tissues. Furthermore, coculture assays indicated that regulating expression of miR-128 in colonic epithelial cells induced the secretion of IL-6 and TNF-α by macrophages. In conclusion, our study demonstrated that miR-128 regulated the p38α/M-CSF signaling pathway to promote chronic inflammatory responses and changes in the immune microenvironment of the colon, thereby offering potential insights into the pathogenesis of CC and therapeutic targets for its treatment.NEW & NOTEWORTHY In this study, we constructed a murine model and identified a novel signaling mechanism involved in the chronic constipation progression. Our findings on the role of miR-128/p38α/M-CSF axis provide new insights into the treatment of chronic constipation.
Insights
MicroRNA-128 plays a key role in chronic constipation (CC) by regulating the p38α/M-CSF pathway, influencing colon inflammation and immune microenvironment. This finding offers new therapeutic targets for CC treatment.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Chronic constipation (CC) significantly impacts quality of life.
- MicroRNAs are implicated in the pathogenesis of functional gastrointestinal disorders.
Purpose of the Study:
- To investigate the molecular mechanism of microRNA-128 (miR-128) in the pathogenesis of chronic constipation.
- To explore the role of miR-128 in regulating inflammatory responses and the colonic immune microenvironment.
Main Methods:
- Construction of a murine model of chronic constipation using morphine and rhubarb.
- miRNA array and bioinformatic analysis to identify miR-128 expression and downstream targets.
- Coculture assays to assess the effect of miR-128 on macrophage cytokine secretion.
Main Results:
- The CC model exhibited downregulated miR-128 and upregulated p38α and macrophage colony-stimulating factors (M-CSFs).
- Elevated inflammatory cytokines (IL-6, TNF-α) and decreased anti-inflammatory cytokines were observed in colonic tissues.
- Regulation of miR-128 in colonic epithelial cells induced pro-inflammatory cytokine secretion by macrophages.
Conclusions:
- miR-128 regulates the p38α/M-CSF signaling pathway, contributing to chronic inflammation and immune microenvironment alterations in the colon.
- The miR-128/p38α/M-CSF axis represents a potential therapeutic target for chronic constipation.
More Related Videos
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019